naftopidil has been researched along with Symptom Cluster in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated the effect of naftopidil an alpha1 adrenoceptor antagonist on non-bacterial chronic pelvic pain syndrome (CPPS) in middle-aged and older male patients with lower urinary tract symptoms (LUTS)." | 7.76 | [Effects of alpha1 adrenoceptor antagonist, naftopidil, on non-bacterial chronic pelvic pain syndrome in patients with lower urinary tract syndrome: evaluation of its efficacy using NIH-CPSI after 4-week treatment]. ( Akasaka, T; Fujishima, M; Funaki, H; Hirano, S; Kudou, T; Ohinata, M; Suzuki, A, 2010) |
| "We investigated the effect of naftopidil an alpha1 adrenoceptor antagonist on non-bacterial chronic pelvic pain syndrome (CPPS) in middle-aged and older male patients with lower urinary tract symptoms (LUTS)." | 3.76 | [Effects of alpha1 adrenoceptor antagonist, naftopidil, on non-bacterial chronic pelvic pain syndrome in patients with lower urinary tract syndrome: evaluation of its efficacy using NIH-CPSI after 4-week treatment]. ( Akasaka, T; Fujishima, M; Funaki, H; Hirano, S; Kudou, T; Ohinata, M; Suzuki, A, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, A | 1 |
| Ohinata, M | 1 |
| Fujishima, M | 1 |
| Hirano, S | 1 |
| Kudou, T | 1 |
| Funaki, H | 1 |
| Akasaka, T | 1 |
| Oshika, T | 1 |
| Ohashi, Y | 1 |
| Inamura, M | 1 |
| Ohki, K | 1 |
| Okamoto, S | 1 |
| Koyama, T | 1 |
| Sakabe, I | 1 |
| Takahashi, K | 1 |
| Fujita, Y | 1 |
| Miyoshi, T | 1 |
| Yasuma, T | 1 |
2 other studies available for naftopidil and Symptom Cluster
| Article | Year |
|---|---|
[Effects of alpha1 adrenoceptor antagonist, naftopidil, on non-bacterial chronic pelvic pain syndrome in patients with lower urinary tract syndrome: evaluation of its efficacy using NIH-CPSI after 4-week treatment].
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Chronic Disease; Drug A | 2010 |
Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical alpha(1)-adrenoceptor antagonist.
Topics: Administration, Topical; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cata | 2007 |